Cooper Companies (NASDAQ:COO – Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Thursday, May 29th. Analysts expect the company to announce earnings of $0.93 per share and revenue of $995.12 million for the quarter. Cooper Companies has set its FY 2025 guidance at 3.940-4.020 EPS.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, analysts expect Cooper Companies to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Cooper Companies Trading Down 2.6%
NASDAQ COO opened at $79.37 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a market capitalization of $15.87 billion, a price-to-earnings ratio of 40.70, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The company’s 50-day simple moving average is $80.29 and its two-hundred day simple moving average is $89.70. Cooper Companies has a one year low of $69.81 and a one year high of $112.38.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on COO
Hedge Funds Weigh In On Cooper Companies
An institutional investor recently raised its position in Cooper Companies stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 48.9% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 22,407 shares of the medical device company’s stock after acquiring an additional 7,363 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Cooper Companies were worth $1,890,000 at the end of the most recent quarter. Institutional investors own 24.39% of the company’s stock.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Stories
- Five stocks we like better than Cooper Companies
- How to invest in marijuana stocks in 7 steps
- $30B AI Opportunity: Will It Power Meta’s Next Surge?
- Stock Average Calculator
- Microsoft Could Rally as EU Antitrust Case Nears Resolution
- What Are Dividend Champions? How to Invest in the Champions
- Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.